A gel-free proteomic-based method for the characterization of Bordetella pertussis clinical isolates

Journal of Microbiological Methods

Volumn 90, Issue 2, 2012, Pages 119-133

  Williamson, Yulanda M ^a   Moura, Hercules ^a   Simmons, Kaneatra ^a   Whitmon, Jennifer ^a   Melnick, Nikkol ^a   Rees, Jon ^a   Woolfitt, Adrian ^a   Schieltz, David M ^a   Tondella, Maria L ^a   Ades, Edwin ^a   Sampson, Jacquelyn ^a   Carlone, George ^a   Barr, John R ^a  

^a GENERAL ELECTRIC COMPANY   (United States)

Author keywords

Antibody affinity; Gel free; LC MS MS; Membrane; Pertussis; Proteomics

Indexed keywords

BACTERIAL PROTEIN; OUTER MEMBRANE PROTEIN; PEPTIDE; TRYPSIN;

ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOTECHNOLOGY; BORDETELLA PERTUSSIS; CONTROLLED STUDY; DATA ANALYSIS; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GEL FREE PROTEOMIC BASED METHOD; LIQUID CHROMATOGRAPHY; MOUSE; NANO LIQUID CHROMATOGRAPHY ELECTROSPRAY IONIZATION MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; QUALITATIVE ANALYSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BORDETELLA PERTUSSIS; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; INFANT; MICE; MICE, INBRED BALB C; PROTEIN BINDING; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; WHOOPING COUGH;

BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS;

EID: 84861742070     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2012.04.007     Document Type: Article

References (46)

1. Advani A., Donnelly D., Hallander H. Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J. Clin. Microbiol. 2004, 42(7):2890-2897.
2. Altindis E., Tefon B.E., Özcengiz Y., Becher D., Hecker M., Özcengiz G. Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins. Vaccine 2009, 27:542-548.
3. Bart M.J., van Gent M., van der Heide H.G., Boekhorst J., Hermans P., Parkhill J., Mooi F.R. Comparative genomics of prevaccination and modern Bordetella pertussis strains. BMC Genomics 2010, 11(627):1-10.
4. Bienvenut W.V., Sanchez J.C., Karmime A., Rouge V., Rose K., Binz P.A., Hochstrasser D.F. Toward a clinical molecular scanner for proteome research: parallel protein chemical processing before and during western blot. Anal. Chem. 1999, 17(21):4800-4807.
5. Bordet J., Gengou O. Le microbe de la coqueluche. Ann. Inst. Pasteur 1906, 20:48-68.
6. Bottero D., Gaillard M.E., Fingermann M., Weltman G., Fernandez J., Sisti F., Graieb A., Roberts R., Rico O., Rios G., Regueira M., Binsztein N., Hozbor D. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin. Vaccine Immunol. 2007, 14:1490-1498.
7. Chen G., Prama B.N. LC-MS for protein characterization: current capabilities and future trends. Expert Rev. Proteomics 2008, 5:435-444.
8. Chitlaru T., Gat O., Grosfeld H., Inbar I., Gozlan Y., et al. Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome. Infect. Immun. 2007, 75:2841-2852.
9. Das P. Whooping cough makes global comeback. Lancet Infect. Dis. 2002, 2:322.
10. Dreisbach A., Hempel K., Buist G., Hecker M., Cecher D., van Dijl J.M. Profiling the surfaceome of Staphylococcus aureus. Proteomics 2010, 10:1-15.
11. Dworzanski J.P., Snyder A.P. Classification and identification of bacteria using mass spectrometry-based proteomics. Exp. Rev. Proteomics 2005, 2(6):863-878.
12. Elder K.D., Harvill E.T. Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. Infect. Immun. 2004, 72:5919-5924.
13. Fuchslocher B., Millar L.L., Cotter P.A. Comparison of bipA alleles within and across Bordetella species. Infect. Immun. 2003, 71:3043-3052.
14. Han X., Aslanian A., Yates J.R. Mass spectrometry for proteomics. Curr. Opin. Chem. Biol. 2008, 12:483-490.
15. Hardwick T.H., Cassiday P., Weyant R.S., Bisgard K.M., Sanden G.N. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg. Infect. Dis. 2002, 8(1):44-49.
16. He Q., Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol. 2008, 3:329-339.
17. http://www.cdc.gov/.
18. Hulbert R.R., Cotter P.A. Laboratory maintenance of Bordetella pertussis. Curr. Protoc. Microbiol. 2009, 15(4B):1.1-1.9.
19. Jabbour R.E., Wade M.M., Desphande S.V., Stanford M.F., Wick C.H., Zullich A.W., Snyder A.P. Identification of Yersinia pestis and Escherichia coli strains by whole cell and membrane protein extracts with mass spectrometry-based proteomics. J. Proteome Res. 2010, 9(7):3647-3655.
20. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74:5383-5392.
21. King A.J., Berbers G., van Oirschot H.F., Hoogerhout P., Knipping K., Mooi F.R. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology 2001, 147:2885-2895.
22. Kudva I.T., Griffin R.W., Garren J.M., Calderwood S.B., John M. Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation. Infect. Immun. 2005, 73(9):5685-5696.
23. Kustos I., Kocsis B., Kilár F. Bacterial outer membrane protein analysis by electrophoresis and microchip technology. Expert Rev. Proteomics 2007, 4(1):91-106.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage t4. Nature 1970, 227:680-685.
25. Lee E.Y., Choi D.S., Kim K.P., Gho Y.S. Proteomics in gram-negative bacterial outer membrane vesicles. Mass Spec. Rev. 2008, 27:535-555.
26. Ling E., Feldman G., Portnoi M., Dagan R., Overweg K., Mulholland F., Chalifa-Caspi V., Wells J., Mizrachi-Nebenzahl Y. Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin. Exp. Immunol. 2004, 138:290-298.
27. Litt D.J., Neal S.E., Fry N.K. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J. Clin. Microbiol. 2009, 47:680-688.
28. Locht C. A common vaccination strategy to solve unsolved problems of tuberculosis and pertussis?. Microbes Infect. 2008, 10:1051-1056.
29. Matoo S., Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 2005, 18(2):326-382.
30. Molloy M.D. Isolation of bacterial cell membrane proteins using carbonate extraction. Methods Mol. Biol. 2008, 424:397-401.
31. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75:4646-4658.
32. O'Farrell P.H. High resolution two-dimensional electrophoresis of protein. J. Biol. Chem. 1975, 250:4007-4021.
33. Oliver D.C., Fernandez R.C. Antibodies to BrkA augment killing of Bordetella pertussis. Vaccine 2001, 20:235-241.
34. Parkhill J., Sebaihia M., Preston A., Murphy L.D., Thomson N., Harris D.E., et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchioseptica. Nat. Genet. 2003, 35:32-40.
35. Poolman J., Hamstra H.J., Barlow A., Kuipers B., Loggen H., Nagel J. Outer membrane vesicles of Bordetella pertussis are protective antigens in the mouse intracerebral challenge model. FDA 1990, 202-206.
36. Singh M., Lingappan K. Whooping cough-the current scene. Chest 2006, 130:1547-1553.
37. Somner U., Peterson J., Pfeiffer M., Schrotz-King P., Morsczeck C. Comparison of surface proteomes of enterotoxigenic (ETEC) and commensal Escherichia coli strains. J Microbiol Methods 2010, 83(2010):13-19.
38. Taylor B., Fahm R. Pasteur Merieux Connaught five-component acellular pertussis vaccine. Biologicals 1999, 27:103-104.
39. Tefon B., MaaB S., Ozcengiz E., Becher D., Hecker M., Ozcengiz G. A comprehensive analysis of Bordetella pertussis surface proteome and identification of new immunogenic proteins. Vaccine 2011, 29(19):3583-3595.
40. Thein M., Sauer G., Paramasivam N., Grin I., Linke D. Efficient subfractionation of gram-negative bacteria for proteomics studies. J. Proteome Res. 2010, 9(12):6135-6147.
41. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gets to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:4350-4354.
42. van den Berg B.M., Beekhuizen H., Mooi F.R., van Furth R. Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells. Infect. Immun. 1999, 67:1050-1055.
43. van Loo I.H., Heuevelman K.J., King A.J., Mooi F.R. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J. Clin. Micro. 2002, 40:1994-2001.
44. Proteome Research: Concepts, Technology and Application 2007, Springer, Berlin, [pp.]. 2nd Ed. M.R. Wilkins, R.D. Appel, K.L. Williams, D.F. Hochstrasser (Eds.).
45. Yu N.Y., Wagner J.R., Laird M.R., Mellj G., Rey S., Lo R., Dao P., Sahinalp S.C., Ester M., Foster L.J., Brinkman F.S. Improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 2010, 26(13):1608-1615.
46. Zhu Y.Z., Cai C.S., Zhang W., Guo H.X., Zhang J.P., Ji Y.Y., Ma G.Y., Wu J.L., Li Q.T., Lu C.P., Guo X.K. Immunoproteomic analysis of human serological antibody responses to vaccination and whole-cell pertussis vaccine (WCV). PLoS One 2010, 5(11):1-11.